Fluoroscopic assessment of feasibility, accuracy andsafety of ultrasound-guided supraneural andinfraneural transforaminal nerve root injections-acomparative study. - NI

Dr RPGMC KANGRA at tanda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1.Patients of either gender between the ages of 18 – 70 years.
•2.Patients with BMI between 18 and 35.
•3.Patients with ASA grading I & II
•4.Patients with back pain of discogenic origin, with or without discomfort to the particular dermatomal distribution, whose activities are restricted for at least six weeks and who do not respond to conservative treatment.
•5.Neurogenic claudication.
•6.MRI results indicating a nerve root involvement or a positive laesegue sign.

•1.Patients who refuse to give consent.
•2.Patients with diagnosed CVA with unilateral or bilateral neurological deficit.
•3.Patients with Segmental instability.
•4.Patients with severe degenerative disc disease with more than 2/3rd of disc height decreased.
•5.Patients allergic to the drugs we use.
•6.Active infection at the site of injection.
•7.Pregnancy.

发起方

Dr RPGMC KANGRA at tanda